GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OSTO:GETI B) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Getinge AB (OSTO:GETI B) Future 3-5Y EPS without NRI Growth Rate : 9.69 (As of Dec. 14, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Getinge AB Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Getinge AB's Future 3-5Y EPS without NRI Growth Rate is 9.69.

Competitive Comparison of Getinge AB's Future 3-5Y EPS without NRI Growth Rate

For the Medical Devices subindustry, Getinge AB's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Getinge AB's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Getinge AB's Future 3-5Y EPS without NRI Growth Rate falls into.


Getinge AB  (OSTO:GETI B) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Getinge AB Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Getinge AB's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Getinge AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OSTO:GETI B) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
OSTO:SECT B OSTO:VITR OSTO:EKTA B OSTO:XVIVO OSTO:MCAP OSTO:CEVI OSTO:BICO OSTO:SEDANA OSTO:BACTI B OSTO:CRAD B ABT SYK BSX MDT XTER:SHL SZSE:300760 EW XAMS:PHIA DXCM STE
Traded in Other Exchanges
GNGBY:USA GNGBF:USA GETIBs:UK 0GZV:UK GTN:Germany
Address
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Website
https://www.getinge.com
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB Headlines

No Headlines